BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5571930)

  • 1. Increase in the vesicular noradrenaline of nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971; 217 Suppl():27P-28P. PubMed ID: 5571930
    [No Abstract]   [Full Text] [Related]  

  • 2. Life cycle of vesicles in sympathetic nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971 Oct; 218 Suppl():67P-68P. PubMed ID: 5130641
    [No Abstract]   [Full Text] [Related]  

  • 3. Depletion of noradrenaline stores in synpathetic nerve terminals.
    Fillenz M; Howe PR
    J Neurochem; 1975 Apr; 24(4):683-8. PubMed ID: 1123623
    [No Abstract]   [Full Text] [Related]  

  • 4. Vesicular noradrenaline stores in peripheral nerves of the rat and their modification by tranylcypromine.
    Fillenz M; Stanford SC
    Br J Pharmacol; 1981 Jun; 73(2):401-4. PubMed ID: 7236991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of noradrenaline content in vesicles of different sympathetic nerve terminals.
    Fillenz M
    J Physiol; 1972 Jul; 224(2):64P-65P. PubMed ID: 4672307
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

  • 7. The noradrenaline content of the varicosities of sympathetic adrenergic nerve terminals in the rat.
    Dahlström A; Häggendal J; Hökfelt T
    Acta Physiol Scand; 1966; 67(3):289-94. PubMed ID: 6007784
    [No Abstract]   [Full Text] [Related]  

  • 8. gamma-Aminobutyric acid reduces the evoked release of [3H]-noradrenaline from sympathetic nerve terminals [proceedings].
    Bowery NG; Hudson AL
    Br J Pharmacol; 1979 May; 66(1):108P. PubMed ID: 454903
    [No Abstract]   [Full Text] [Related]  

  • 9. Vesicular noradrenaline in nerve terminals of rat heart following inhibition of monoamine oxidase and administration of noradrenaline.
    Fillenz M; Howe PR; West DP
    Neuroscience; 1976; 1(2):113-6. PubMed ID: 1004706
    [No Abstract]   [Full Text] [Related]  

  • 10. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in sympathetic nerve terminals in the heart of cold-exposed rats.
    Fillenz M; Stanford SC; Coles BG
    J Neurochem; 1993 Jul; 61(1):132-7. PubMed ID: 8515259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings.
    Kopin IJ
    Pharmacol Rev; 1966 Mar; 18(1):513-23. PubMed ID: 5904165
    [No Abstract]   [Full Text] [Related]  

  • 13. Extent of release and elimination of noradrenaline at peripheral adrenergic nerve terminals.
    Folkow B; Häggendal J; Lisander B
    Acta Physiol Scand Suppl; 1967; 307():1-38. PubMed ID: 4297559
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of uptake by adrenergic nerve terminals on the sensitivity of arterial vessels to topically applied noradrenaline.
    Marshall JM
    Br J Pharmacol; 1977 Nov; 61(3):429-32. PubMed ID: 588808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 16. Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea-pig atria.
    Van Orden LS; Schaefer JM; Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1974 Mar; 188(3):668-75. PubMed ID: 4131521
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Intraneuronal distributions and metabolic pathways of the adrenergic neurotransmitter.
    Stéfano FJ
    Acta Physiol Lat Am; 1973; 23(6):626-8. PubMed ID: 4369053
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative histofluorescent study of cardiac sympathetic nerves and adrenal catecholamines in rats under immobilization stress and administered a toxic dose of noradrenaline].
    Serov RA; Chekareva GA; Sokolova NN; Mikhaĭlenko TF
    Farmakol Toksikol; 1987; 50(4):38-41. PubMed ID: 3666114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and synaptosomal transport of 3 H-norepinephrine and 3 H-5-hydroxytryptamine.
    Ciofalo FR
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):551-4. PubMed ID: 4699482
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine.
    Vanhoutte PM; Lorenz RR; Tyce GM
    J Pharmacol Exp Ther; 1973 May; 185(2):386-94. PubMed ID: 4703828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.